SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-041998
Filing Date
2023-11-20
Accepted
2023-11-20 09:00:30
Documents
64
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 957004
2 ex10-1.htm EX-10.1 212359
3 ex10-2.htm EX-10.2 211894
4 ex10-3.htm EX-10.3 108833
5 ex10-4.htm EX-10.4 109108
6 ex10-5.htm EX-10.5 68149
7 ex10-6.htm EX-10.6 60619
8 ex10-7.htm EX-10.7 100301
9 ex31-1.htm EX-31.1 18766
10 ex31-2.htm EX-31.2 18644
11 ex32-1.htm EX-32.1 7974
12 ex32-2.htm EX-32.2 7828
  Complete submission text file 0001493152-23-041998.txt   5870214

Data Files

Seq Description Document Type Size
13 XBRL SCHEMA FILE adxs-20230930.xsd EX-101.SCH 37241
14 XBRL CALCULATION FILE adxs-20230930_cal.xml EX-101.CAL 55688
15 XBRL DEFINITION FILE adxs-20230930_def.xml EX-101.DEF 112486
16 XBRL LABEL FILE adxs-20230930_lab.xml EX-101.LAB 335144
17 XBRL PRESENTATION FILE adxs-20230930_pre.xml EX-101.PRE 250566
58 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 748626
Mailing Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852
Business Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852 732 545 1590
Ayala Pharmaceuticals, Inc. (Filer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36138 | Film No.: 231420919
SIC: 2834 Pharmaceutical Preparations